The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELYRIN | ORD | 00445A100 | 19,505,259 | 2,889,668 | SH | SOLE | 2,889,668 | 0 | 0 | |||
ADAGENE | ADR | 005329107 | 739,200 | 264,000 | SH | SOLE | 264,000 | 0 | 0 | |||
AKERO THERAPEUTICS | COM | 00973Y108 | 132,210,562 | 5,233,989 | SH | SOLE | 5,233,989 | 0 | 0 | |||
ALIGNMENT HEALTHCARE | COM | 01625V104 | 302,526,882 | 60,993,323 | SH | SOLE | 60,993,323 | 0 | 0 | |||
ALKAMI | COM | 01644J108 | 460,191,333 | 18,729,806 | SH | SOLE | 18,729,806 | 0 | 0 | |||
BLEND LABS | CL A | 09352U108 | 62,180,430 | 19,132,440 | SH | SOLE | 19,132,440 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS | ADR | 152309100 | 109,404,543 | 9,681,818 | SH | SOLE | 9,681,818 | 0 | 0 | |||
DLOCAL | CL A | G29018101 | 939,428,417 | 63,906,695 | SH | SOLE | 63,906,695 | 0 | 0 | |||
EUROPEAN WAX CENTER | CL A | 29882P106 | 170,174,186 | 13,110,492 | SH | SOLE | 13,110,492 | 0 | 0 | |||
GROVE COLLABORATIVE | CL A | 39957D201 | 1,563,153 | 936,020 | SH | SOLE | 936,020 | 0 | 0 | |||
HIRERIGHT | COM | 433537107 | 458,208,244 | 32,109,898 | SH | SOLE | 32,109,898 | 0 | 0 | |||
HUTCHMED | ADS | 44842L103 | 67,200,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | |||
IMMUNOCORE | ADS | 45258D105 | 97,934,460 | 1,506,684 | SH | SOLE | 1,506,684 | 0 | 0 | |||
MOBILEYE | CL A | 60741F104 | 38,414,074 | 1,194,839 | SH | SOLE | 1,194,839 | 0 | 0 | |||
OPENDOOR | COM | 683712103 | 19,154,203 | 6,321,519 | SH | SOLE | 6,321,519 | 0 | 0 | |||
PHARVARIS | COM | N69605108 | 174,047,234 | 7,531,252 | SH | SOLE | 7,531,252 | 0 | 0 | |||
RISKIFIED | CL A | M8216R109 | 28,808,239 | 5,324,998 | SH | SOLE | 5,324,998 | 0 | 0 | |||
ROYALTY PHARMA | SHS CLASS A | G7709Q104 | 45,555,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
SQUARESPACE | CL A | 85225A107 | 386,667,500 | 10,611,073 | SH | SOLE | 10,611,073 | 0 | 0 | |||
THIRD HARMONIC BIO | COM | 88427A107 | 27,930,713 | 2,958,762 | SH | SOLE | 2,958,762 | 0 | 0 | |||
WISH | CL A | 21077C305 | 3,468,715 | 609,616 | SH | SOLE | 609,616 | 0 | 0 | |||
XP, INC | CL A | G98239109 | 759,991,029 | 29,617,733 | SH | SOLE | 29,617,733 | 0 | 0 |